Comirnaty 30 micrograms/dose dispersion for injection COVID-19 mRNA Vaccine, Spikevax 0.2 mg/mL dispersion for injection clinical trials

Temporal kinetics of antibody and cellular response markers and relative impact of revaccination in patients recovered from COVID-19 after treatment with monoclonal antibodies

This study looks at how well different COVID-19 vaccines work in people who've had COVID and were treated with special antibody medicines. It checks how their immune system responds over time and if getting a booster vaccine at 4 or 12 months makes a difference.